Clinical Trial Update: Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating nivolumab and ipilimumab with stereotactic body radiation therapy in salivary gland cancers; study status completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Salivary Gland Cancer
• Salivary Gland Cancer

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: University of Washington | Conditions: Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Lung | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-12-29